Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (291-300 of 399) with videos related to

Pageof 40
Sort By:
Leukemia|June 1, 1996
Prognostic factors in the acute lymphoid and myeloid leukemias of infantsC H Pui, R C Ribeiro, D Campana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Leukemia|August 1, 1996
Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemiaJ R Kane, D R Head, L Balazs, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Leukemia & Lymphoma|February 25, 2014
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupGeorge S Laszlo, Rhonda E Ries, Chelsea J Gudgeon, et al.
Journal of Cancer Research and Clinical Oncology|June 6, 2013
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?P Gazzaniga, C Raimondi, A Gradilone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trialTorben S Mikkelsen, Alex Sparreboom, Cheng Cheng, et al.
Leukemia|March 2, 2011
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology GroupJ N Berman, R B Gerbing, T A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemiaKristine R Crews, Varsha Gandhi, Deo Kumar Srivastava, et al.
Pageof 40

Showing results (291-300 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|June 1, 1996
Prognostic factors in the acute lymphoid and myeloid leukemias of infantsC H Pui, R C Ribeiro, D Campana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Leukemia|August 1, 1996
Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemiaJ R Kane, D R Head, L Balazs, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Leukemia & Lymphoma|February 25, 2014
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupGeorge S Laszlo, Rhonda E Ries, Chelsea J Gudgeon, et al.
Journal of Cancer Research and Clinical Oncology|June 6, 2013
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?P Gazzaniga, C Raimondi, A Gradilone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trialTorben S Mikkelsen, Alex Sparreboom, Cheng Cheng, et al.
Leukemia|March 2, 2011
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology GroupJ N Berman, R B Gerbing, T A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemiaKristine R Crews, Varsha Gandhi, Deo Kumar Srivastava, et al.
Pageof 40